Source: RTTNews

InvaGen Pharmaceuticals: Cipla's US Unit InvaGen Recalls Vigabatrin For Oral Solution

InvaGen Pharmaceuticals Inc., affiliated to Cipla Ltd., is recalling one lot of Vigabatrin for Oral Solution, USP, citing leakage issues, according to the U.S Food and Drug Administration or FDA.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Nikhil Lalwani's photo - CEO of InvaGen Pharmaceuticals

CEO

Nikhil Lalwani

CEO Approval Rating

70/100

Read more